Significant Ownership of BridgeBio Pharma LLC

Signature - Title: /s/ Neil Kumar - Neil Kumar, Chief Executive Officer
Location: Palo Alto, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by BridgeBio Pharma LLC.

Notify me when BridgeBio Pharma LLC files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
	BridgeBio Oncology Therapeutics, Inc.	Common Stock, $0.0001 par value	17.5%			13,878,554		BridgeBio Pharma LLC	11 Aug 2025

Schedules 13D/G Reported by BridgeBio Pharma LLC:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.